Brand vs Generic Finasteride: Real Monthly Cost
How does brand-name Propecia compare with generic finasteride on price?
If you're paying for the brand here, you're paying for the name on the box and not for anything the tablet does differently in your body. It's the same molecule at the same 1 mg dose with the same expected effect on your scalp, and usually a ten-to-one difference at the register. That gap isn't a coupon you have to hunt for, it's just what happened to the price after the patent ran out in 2013.
Brand-name Propecia commonly runs $70 to $130 for a thirty-day supply of 1 mg tablets while generic finasteride 1 mg sells for $10 to $30 at retail and drops to $5 to $15 with a discount card, a ten-to-one spread for the identical active ingredient at the identical strength.
What is the typical monthly price difference between the brand-name tablet and the generic version?
Look at a year instead of a month and the difference stops being pocket change. This drug only works while you keep taking it, so the fill you pick today is one you'll repeat for years, and a gap that looks small per month compounds into real money. Five years in, you're comparing a few hundred dollars against several thousand.
| Cost basis | Brand-name 1 mg | Generic 1 mg |
|---|---|---|
| 30-day list price | $70 to $130 | $10 to $30 |
| 30 days with a free card | A few percent off | $5 to $15 |
| 90-day supply | Scales close to linearly | $20 to $30 |
| One year of treatment | $840 to $1,560 | $100 to $150 |
A year of the branded 1 mg tablet costs roughly $840 to $1,560 against about $100 to $150 for the generic, and generic pricing swings enough between counters that a $12 fill at one pharmacy and a $38 fill two miles away for identical tablets is normal rather than an error.
Why did the price gap widen after the original patent expired?
Nothing clever happened here. A small molecule lost its exclusivity, a crowd of manufacturers showed up with an identical tablet, and the price fell toward what it costs to press one. The gap widened rather than closed because the brand held its list price on purpose.
- Patent expiry in 2013: The 1 mg hair-loss formulation lost US protection and the first abbreviated applications cleared.
- First competitor arrives: One generic entrant typically takes about thirty percent off the branded price.
- The field fills in: By the time five generics compete for the same prescriptions, prices sit roughly eighty-five percent below branded list.
- The brand stands still: Cutting a list price ripples through contracts, rebates and international reference pricing, so holding it on a shrinking base pays better.
Finasteride 1 mg lost its US patent protection in 2013, and a single generic competitor cuts price by roughly thirty percent while five competing generics push it about eighty-five percent below the branded list price.
Are the brand and the generic chemically and therapeutically equivalent?
Equivalence isn't a marketing word in this context, it's a finding a manufacturer has to earn in a study. Before a generic can sit on the shelf beside the brand, it has to prove it puts the same amount of drug into your blood at the same rate. That's why the brand's multi-year hair-count evidence carries over to a tablet the brand never made.
- Same active moiety: Finasteride, 1 mg, oral tablet, same approved indication as the reference product.
- Bioequivalence band: Ninety percent confidence interval for peak and total exposure inside 80% to 125%.
- What may differ: Binder, filler, disintegrant, film coating, dyes, tablet shape and imprint.
- Same oversight after approval: Identical inspection regime and batch testing as branded plants.
A generic finasteride must show that the ninety percent confidence interval for both peak concentration and total exposure falls entirely inside the eighty to one hundred twenty-five percent band against the reference product, which earns it a therapeutic equivalence rating and allows substitution at the counter.
How does insurance coverage differ between the branded product and the generic?
Here's the part that trips people up: for most men, insurance never enters the conversation at all. Plans treat hair loss as cosmetic and exclude the branded and the generic version equally, which drops you straight back to cash price. That's not a loophole to argue your way around, it's how the benefit is written.
Commercial plans and public programs generally exclude finasteride prescribed for androgenetic alopecia as cosmetic, and where coverage exists the generic sits on the lowest tier at a $5 to $15 copay while the brand is non-preferred or excluded outright.
What do pharmacy discount cards and cash-pay programs do to each price?
Discount cards work unusually well on this drug, and not for the reason most people assume. The generic is already cheap to produce, so the negotiated cash rate the card networks publish sits close to the floor. Point the same card at the brand and almost nothing happens.
A free discount card commonly brings a thirty-day generic finasteride fill from a $20 to $30 shelf price down to $5 to $15 while trimming only a few percent off the brand, so using a card widens the price gap instead of narrowing it.
Does choosing the 1 mg hair-loss tablet or the 5 mg prostate tablet change the cost arithmetic?
Somebody always brings up quartering the 5 mg prostate tablet, and on paper the arithmetic looks brilliant: five times the drug for the same money per tablet. The catch is that your generic 1 mg fill already costs five to fifteen dollars a month, so you'd be cutting pills to save a few dollars against some genuinely bad tradeoffs.
| Consideration | 1 mg tablet | 5 mg tablet quartered |
|---|---|---|
| Monthly cost | $5 to $15 generic | A few dollars less |
| Dose accuracy | Exact 1 mg, every dose | Fragments vary meaningfully in weight |
| Tablet coating | Intact | Broken, creating loose drug dust |
| Prescribing status | Approved for scalp hair | Off-label for this use |
Finasteride tablets are film coated and not scored for quartering, so splitting a 5 mg tablet produces fragments that vary meaningfully in weight and saves only a few dollars a month against a generic 1 mg fill that already runs $5 to $15.
Are there quality or manufacturing reasons someone might still pay for the brand?
Ask this one precisely and the honest list gets short fast. Nothing published shows the branded 1 mg tablet beating an approved generic on hair count, shedding or maintenance, and the equivalence standard exists specifically so you don't have to wonder. What the premium actually buys you is a tablet that always looks the same.
- Appearance drift: Your pharmacy may swap generic manufacturers between fills, changing color and shape.
- The free fix: Ask the pharmacy to keep supplying one manufacturer, which most will do.
- The real quality risk: Unapproved online sellers with no assurance of content or dose.
- Your safeguard: Licensed pharmacy, prescription required, approved manufacturer and imprint on the tablet.
There is no published evidence that the branded 1 mg tablet outperforms an approved generic on hair count, shedding or maintenance, so the money spent on the brand buys consistency of tablet appearance rather than a better result.
What consultation and monitoring costs sit on top of the tablet price either way?
When the tablet itself costs single-digit dollars, the appointment can cost more than the drug does. That's worth knowing before you assume the pharmacy quote is your whole bill. The useful part is that these costs land the same either way, so they never close the gap.
- Initial consultation: A modest insured copay up to $150 or $200 self-pay with a dermatologist or primary care clinician, or $0 to $25 through an online prescribing service.
- Renewal touchpoint: Prescriptions typically run six to twelve months, so you're back once or twice a year, sometimes as a brief message-based check-in.
- PSA awareness: Routine labs aren't standard for healthy men, but this drug lowers prostate-specific antigen readings, with the labelled 1 mg studies showing a mean fall from 0.7 ng/mL at baseline to 0.5 ng/mL at month twelve, so any clinician ordering that test needs to know you're taking it.
Consultation and monitoring costs are identical whichever version is dispensed, so adding roughly $100 a year of visit cost to a $120 annual generic supply still lands far below the price of the branded tablets alone.
How do telehealth subscription prices compare with filling either version at a pharmacy?
A subscription isn't really selling you a tablet, it's selling you the removal of friction. No appointment to book, no pharmacy to visit, no renewal to remember, all folded into one recurring charge. What's dispensed is almost always the generic, because nobody is buying branded tablets at list to resell inside a thirty dollar plan.
A typical hair-loss telehealth subscription runs $20 to $35 a month and dispenses the generic, while the unbundled route of a ninety-day generic fill at $20 to $30 plus one consultation a year usually costs less over a full year, sometimes by half.
